Sort
82,697 grants matching “vaccine development”
Cellular Vaccines for Cancer Therapy
$1,171,386University Of Michigan At Ann Arbor · P01 · FY2003 · CA
Reactions And Immunochemistry Of Carbohydrates
$1,170,786Pavol Kovac · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Control of Epidemic Influenza
$1,170,764Pedro A Piedra · Baylor College Of Medicine · R01 · FY2006 · AI
Novel immunotherapeutics against multidrug-resistant Neisseria gonorrhoea
$1,170,759Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · AI
Immunology of Acute and Chronic Viral Hepatitis
$1,170,726Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Development of MecVax, a Cross Protective Subunit Vaccine for ETEC
$1,170,694Weiping Zhang · University Of Illinois At Urbana-Champaign · R01 · FY2023 · AI
Safeguard the Household
$1,170,592Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · U19 · FY2007 · AI
Adjuvant Development in the context of a vaccine to protect against tuberculosis
$1,170,507Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2021 · AI
Molecular Regulation of B-Cell Differentiation and Function
$1,170,431Herbert Morse · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Malaria Parasite Ligands And Host Cell Receptors
$1,170,400Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis
$1,170,282Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Novel Targets for Immunotherapy
$1,170,238Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Discovery of B. pseudomallei therapeutics for Biodefense
$1,170,128Donald T Moir · Microbiotix, Inc · R44 · FY2007 · AI
Combinational Immunotherapies to Amplify Vaccine Induce*
$1,169,956Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2006 · CA
UAB AIEDRP: Immune Control and Escape in Acute Infection
$1,169,746University Of Alabama At Birmingham · U01 · FY2002 · AI
Phase I therapeutic testing of viral-vectored vaccines that shift CD8+ T cell immunodominance to conserved regions of HIV-1
$1,169,548Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U01 · FY2018 · AI
Influenza Viral Pathogenesis
$1,169,285Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
REGULATION OF ANTI-TUMOR IMMUNITY
$1,169,175Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2008 · CA
Spirulina oral supplement for enhancing host resilience to virus infection
$1,169,058Ikhlas Ahmad Khan · University Of Mississippi · U19 · FY2021 · AT
Harnessing Highly Networked HLA-E-Restricted CTL Epitopes to Achieve a Broadly Effective HIV Cure
$1,169,000Gaurav Das Gaiha · Massachusetts General Hospital · DP1 · FY2023 · DA
Harnessing Highly Networked HLA-E-Restricted CTL Epitopes to Achieve a Broadly Effective HIV Cure
$1,169,000Gaurav Das Gaiha · Massachusetts General Hospital · DP1 · FY2024 · DA
Harnessing Highly Networked HLA-E-Restricted CTL Epitopes to Achieve a Broadly Effective HIV Cure
$1,169,000Gaurav Das Gaiha · Massachusetts General Hospital · DP1 · FY2025 · DA
The Neural Basis of the Brain-Body Connection
$1,168,788Peter L Strick · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AT
The Neural Basis of the Brain-Body Connection
$1,168,788Peter L Strick · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AT
The Neural Basis of the Brain-Body Connection
$1,168,788Peter L Strick · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AT